Searched for
THE NATIONAL INSTITUTE OF IMMUNOLOGY
Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...- ACC clears Dr Rajeev Singh Raghuvanshi’s reappointment as Drugs Controller (India)Dr Rajeev Singh Raghuvanshi will continue as Drugs Controller (India) at CDSCO. His reappointment is on a contract basis for one year start...
- Rajeev Raghuvanshi appointed as new Drug Controller General of IndiaOn November 11, last year, Dr VG Somani's term as DCGI was extended for three months, for the second time, coming into effect on November 1...
- UPSC recommends Rajeev Singh Raghuvanshi as next DCGIThe UPSC recommendation has to be approved by the Health Ministry, followed by approval of the Appointments Committee of Cabinet led by Pri...
- Dr Subhash Babu, first Indian scientist to be awarded Bailey K. Ashford MedalThe American Society of Tropical Medicine and Hygiene (ASTMH) is the world's largest scientific organization in tropical medicine, and the ...
- Covaxin has cellular immune memory to Covid for at least 6 months: National Institute of ImmunologyNII has also provided services for COVID-19 research. Under this programme, 65 Medical laboratory technologists (MLTs)/lab technicians were...
- Common cold virus saved lives in IndiaOne of the biggest mysteries of the Covid-19 infection in India relative to other countries like the US and UK has been the lower mortality...
- Herd immunity inference from Delhi's sero survey to be taken with pinch of salt, say scientistsOn Tuesday, the Delhi government announced the results of the fifth sero survey, with a sample of 28,000 across 11 districts in Delhi. The ...
- 'Next-gen' COVID-19 vaccines may be needed to tackle emerging variants, say scientistsWork on vaccines will have to continue on parallel tracks - one to tackle the SARS-CoV-2 virus with first generation vaccines and the other...
- Localised herd immunity, young population behind dip in India's COVID count?As scientists attempt to understand India's sliding COVID count, the country on Tuesday recorded 16,375 new COVID-19 cases, more than six t...
- Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists sayThe decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scien...
- Six months since lockdown: Strides in testing, vaccine devt but COVID crisis far from over in India, say scientistsSix months on, India has the second highest number of cases in the world after the US with a tally of 57.32 lakh cases, 86,508 people testi...
- Rapid antigen tests can be no more than adjunct to RT-PCR in corona battle: ScientistsThe ministry noted that symptomatic cases tested negative by RATs are not followed up by RT-PCR testing in some large states. The idea is t...
- Presence of antibodies may not guarantee protection from COVID-19, say scientistsAs worries over India's COVID-19 spike mount - the country added 90,062 cases on Monday to take its tally past the 42-lakh mark - scientist...
- Indian scientists find higher viral load in asymptomatic COVID-19 patientsThe researchers, including those from the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad, advise testing asymptomatic pr...
- Scientists sceptical about Russia's Covid vaccine, cite lack of evidence for efficacyWhile the country hopes to start mass-producing the vaccine by October and plans to offer the first doses to essential workers, many in the...
- Karnataka keen to set up immunology research centre, says Dy CMHe also said the state government is also very keen on introducing new ways of covid diagnostic tests. This is also a sensitive issue in th...
- COVID-19: 16 companies get funds for R&D workThe department of biotechnology has granted funds to 16 companies for developing drugs, vaccines and devices to fight the Covid-19 pandemic...
- Indian Immunologicals to unveil feed for lab animals used for clinical trialsAt present, India houses hundreds of scientific bodies, both in public and private sectors, which together have nearly 10 million lab anima...
- Indian Immunologicals Ltd produces 1 bn doses of Foot and Mouth disease vaccineIndian Immunologicals Ltd, a wholly owned subsidiary of NDDB, has produced one billion doses of the Foot and Mouth Disease Vaccine.
Load More
